Ramipril and hydrochlorothiazide (Tritazide and related) indications, contraindications and posology updated in a review by the CHMP

The CHMP has issued a question and answer document dated 18 December 2008, about the review of Titrazide (ramipril and hydrochlorothiazide) and associated names: Questions and answers on the referral for Tritazide tablets containing ramipril and hydrochlorothiazide 2.5/12.5 mg, 5/12.5 mg, 5/25 mg The European Medicines Agency¬† (EMEA) has completed a review of Tritazide. The […]